Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J Bernhard
Estimating Prognosis and Palliation Based on Tumour Marker CA 19-9 and Quality of Life Indicators in Patients With Advanced Pancreatic Cancer Receiving Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
Related publications
Assessing Prognosis in Metastatic Pancreatic Cancer by the Serum Tumor Marker CA 19-9: Pretreatment Levels or Kinetics During Chemotherapy?
Oncology Research and Treatment
Cancer Research
Oncology
Hematology
Prognostic and Therapeutic Significance of Carbohydrate Antigen 19-9 as Tumor Marker in Patients With Pancreatic Cancer
Oncology
Medicine
Cancer Research
Oncology
A High Monocyte-To-Lymphocyte Ratio Predicts Poor Prognosis in Patients With Advanced Gallbladder Cancer Receiving Chemotherapy
Cancer Epidemiology Biomarkers and Prevention
Medicine
Epidemiology
Oncology
Appropriateness of Quality Indicators for Older Patients With Advanced Dementia and Poor Prognosis
Highly Sensitive Plasmonic Detection of the Pancreatic Cancer Biomarker CA 19-9
Scientific Reports
Multidisciplinary
Quality of Life in Metastatic Pancreatic Cancer Patients Receiving Liposomal Irinotecan Plus 5-Fluorouracil and Leucovorin
European Journal of Cancer
Cancer Research
Oncology
Effects of a Multidisciplinary Quality of Life Intervention on Sleep Quality in Patients With Advanced Cancer Receiving Radiation Therapy – CORRIGENDUM
Palliative and Supportive Care
Medicine
Clinical Psychology
Psychiatry
Mental Health
Nursing
Assessment of Nutritional Status, Digestion and Absorption, and Quality of Life in Patients With Locally Advanced Pancreatic Cancer
Gastroenterology Research and Practice
Hepatology
Gastroenterology
Levels of CEA and Ca 19 - 9 in the Sera and Peritoneal Cavity in Patients With Gastric and Pancreatic Cancers
Acta Cirurgica Brasileira
Surgery
